Golden Lily

Golden Lily (Beijing) Biotechnology, also known as Jinbaihe, is a prominent Chinese healthcare company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. Founded in 1995, the company has established itself as a leader in rapid diagnostic testing, particularly utilizing colloidal gold and ELISA technologies for infectious diseases and tumor markers. Their product portfolio includes widely used kits for HIV, Syphilis, Hepatitis, and various cardiac and tumor markers, serving clinical laboratories and hospitals across China and international markets. As a National High-tech Enterprise, Golden Lily maintains rigorous quality standards with ISO 13485 certification and numerous NMPA (formerly CFDA) registrations. The company continues to expand its diagnostic capabilities into areas such as drug of abuse testing and respiratory pathogen detection.